FreeTheAI

Liberty All-Star Growth Fund Shifts Portfolio in September Report

NeutroBaixo impacto
ASGUS$ 4,98 −1,87%

Liberty All-Star Growth Fund, Inc. (NYSE:ASG) published its monthly report for September 2026. During the month, the fund adjusted its stock holdings by adding three new companies and selling off six existing investments. The fund's market price decreased 1.87% to close at $4.975 per share.

The closed-end fund made changes across its growth strategy, which relies on three distinct asset managers overseeing small, mid, and large-cap equities. The new additions to the portfolio include pharmaceutical and healthcare-focused firms such as Argenx SE, Royalty Pharma PLC, and IQVIA Holdings, Inc. On the selling side, managers completely exited investments in several notable companies, including Gilead Sciences, Inc., Marriott International, Inc., Vertiv Holdings Co., FTAI Aviation, Ltd., Viking Holdings, Ltd., and Credo Technology Group Holding, Ltd.

Fund managers noted that year-to-date distribution estimates currently contain no return of capital. Shareholders will receive formal tax accounting on Form 1099-DIV following the close of the calendar year to confirm final distribution sources.

Pontos principais

  • Liberty All-Star Growth Fund, Inc. (NYSE:ASG) altered its portfolio lineup during September 2026.
  • Managers brought three new equities into the fund, including Royalty Pharma PLC and IQVIA Holdings, Inc.
  • The fund fully disposed of six equities, including Gilead Sciences, Inc. and Marriott International, Inc.
  • Preliminary guidance indicates distributions for 2026 do not include any return of capital.
  • Shares of the closed-end fund moved down 1.87% to $4.975.

Escrito pela nossa IA a partir de fontes especializadas do mercado na web. Pode conter erros: confira os fatos antes de agir. Resumos feitos com a API de IA grátis da FreeTheAI.org

Como escrevemosAviso legal

Perguntas e respostas

What changes did Liberty All-Star Growth Fund make in September 2026?

The fund added three new stock positions and completely sold out of six existing portfolio holdings during September 2026.

Did Liberty All-Star Growth Fund buy new healthcare stocks?

Yes, the fund initiated new positions in healthcare and pharmaceutical names, including Argenx SE, IQVIA Holdings, Inc., and Royalty Pharma PLC.

How did Liberty All-Star Growth Fund shares perform?

Shares of the fund fell 1.87% to trade at $4.975 following the release of its monthly portfolio update.